CHEMBIO DIAGNOSTICS INC's ticker is CEMI and the CUSIP is 163572209. A total of 62 filers reported holding CHEMBIO DIAGNOSTICS INC in Q2 2021. The put-call ratio across all filers is 3.37 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2023 | $69 | +130.0% | 157,100 | +15.2% | 0.00% | – |
| Q4 2022 | $30 | -99.9% | 136,400 | +20.1% | 0.00% | – |
| Q3 2022 | $41,000 | +173.3% | 113,600 | +383.4% | 0.00% | – |
| Q2 2022 | $15,000 | -90.7% | 23,500 | -56.9% | 0.00% | – |
| Q2 2021 | $162,000 | -70.2% | 54,474 | -64.8% | 0.00% | -100.0% |
| Q1 2021 | $543,000 | +158.6% | 154,640 | +348.2% | 0.00% | – |
| Q2 2019 | $210,000 | -46.2% | 34,500 | -50.9% | 0.00% | – |
| Q1 2019 | $390,000 | -18.2% | 70,300 | -16.6% | 0.00% | -100.0% |
| Q4 2018 | $477,000 | +3.7% | 84,299 | +92.5% | 0.00% | – |
| Q3 2018 | $460,000 | +90.9% | 43,800 | +101.8% | 0.00% | – |
| Q2 2018 | $241,000 | -39.0% | 21,700 | -55.0% | 0.00% | -100.0% |
| Q2 2016 | $395,000 | +375.9% | 48,200 | +246.8% | 0.00% | – |
| Q1 2016 | $83,000 | +18.6% | 13,900 | +6.1% | 0.00% | – |
| Q4 2015 | $70,000 | – | 13,100 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Penbrook Management LLC | 348,960 | $1,225,000 | 0.88% |
| PERKINS CAPITAL MANAGEMENT INC | 289,680 | $1,017,000 | 0.59% |
| Newbridge Financial Services Group, Inc. | 87,185 | $306,000 | 0.22% |
| FRIESS ASSOCIATES LLC | 144,084 | $506,000 | 0.20% |
| Union Square Park Capital Management, LLC | 75,000 | $263,000 | 0.09% |
| PERRITT CAPITAL MANAGEMENT INC | 30,651 | $108,000 | 0.06% |
| Ikarian Capital, LLC | 219,109 | $769,000 | 0.03% |
| GAGNON SECURITIES LLC | 48,072 | $169,000 | 0.03% |
| SEGALL BRYANT & HAMILL, LLC | 703,826 | $2,475,000 | 0.02% |
| Phocas Financial Corp. | 30,000 | $105,000 | 0.01% |